Capecitabine (X) improves quality of life (QoL) in patients (pts) with metastatic breast cancer (MBC).

被引：0
|
作者：
Segalla, J
Oliveira, C
Cabral, S
Lago, S
Ribeiro, R
Perdicaris, M
Abdo, E
Garicochea, B
Moore, F
Fabiani, C
机构：
[1] Fdn Amaral Carvalho, Jau Sao Paulo, Brazil
[2] Inst Brasileiro Controle Cancer, Sao Paulo, Brazil
[3] PUC, Hosp Sao Lucas, Porto Alegre, RS, Brazil
[4] Ctr Quimioterapia Antiblastica & Imunoterapia, Belo Horizonte, MG, Brazil
[5] Inst Canc Ceara, Fortaleza, Ceara, Brazil
[6] Beneficencia Portuguesa Santos, Santos, Brazil
[7] Hosp Perola Byngton, Sao Paulo, Brazil
[8] Fdn Benjamin Guimaraes, Belo Horizonte, MG, Brazil
[9] CEPON, Florianopolis, SC, Brazil
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2004年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S201 / S201
页数：1
相关论文
共 50 条
  • [31] Quality of life (QoL) in patients (pts) with locally advanced or metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes who received eribulin or capecitabine: A Phase Ill, open-label, randomized study
    Cortes, J.
    Awada, A.
    Kaufmann, P. A.
    Yelle, L.
    Perez, E. A.
    Velikova, G.
    Wanders, J.
    Olivo, M.
    He, Y.
    Ductus, C.
    Simons, R.
    Bischoff, J.
    Twelves, C.
    [J]. ONKOLOGIE, 2013, 36 : 97 - 97
  • [32] All oral combination of vinorelbine and capecitabine as a first line treatment in patients (pts) with metastatic breast cancer (MBC)
    Shehata, S.
    Khalaf, M.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [33] Prospective evaluation of quality of life (QOL) in patients with metastatic breast cancer
    Conforti, Rosa
    di Palma, Morio
    Abuin, Gonzalo Gomez
    Delaloge, Suzette
    Spielmann, Marc
    Andre, Fabrice
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 125 - 125
  • [34] Quality of life (QoL) in patients (pts) with locally advanced or metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes who received eribulin mesylate or capecitabine: A phase III, open-label, randomized study
    Cortes, Javier
    Awada, Ahmad
    Kaufman, Peter Andrew
    Yelle, Louise
    Perez, Edith A.
    Velikova, Galina
    Wanders, Jantien
    Olivo, Martin S.
    He, Yi
    Dutcus, Corina
    Simons, W. Robert
    Twelves, Christopher
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Capecitabine (X) in the first-line treatment of metastatic breast cancer (MBC).
    Harbeck, N.
    Kaufmann, M.
    Siedentopf, F.
    Dalivoust, P.
    Debled, M.
    Robert, N. J.
    O'Shaughnessy, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [36] ORAL CHEMOTHERAPY TO OPTIMIZE CARE OF METASTATIC BREAST CANCER (MBC) PATIENTS: CONSIDERING WOMEN'S PREFERENCE AND QUALITY OF LIFE (QOL)
    Strada, M. R.
    Palumbo, R.
    Frascaroli, M.
    Jedrychowska, I.
    Albanese, D.
    Malago, G.
    Petracca, M.
    Bernardo, G.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 107 - 107
  • [37] Treatment goals and quality of life (QOL) in a survey of patients with ER+/HER2-metastatic breast cancer (mBC)
    Sammons, Sarah L.
    Meisel, Jane
    Shanahan, Kelly
    Pluard, Timothy
    Kozlowski, Monica
    Carroll, Dominic
    Attias, Elizabeth
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [38] Capecitabine (X) plus vinorelbine (N) as secondline therapy in Chinese patients (PTS) with metastastic breast cancer (MBC)
    Xu, Binghe
    Wu, Qing
    Zhou, Meizhen
    Tong, Zhongsheng
    Li, Hecheng
    Li, Li
    Wu, Guoqing
    Tian, Lijun
    Shi, Junyi
    Li, Lejing
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 75 - 75
  • [39] Phase II trial of weekly docetaxel (DOC) and prolonged capecitabine (C) in metastatic breast cancer (MBC) patients (pts).
    Shapiro, CL
    Ramaswamy, B
    Rhoades, C
    Kendra, K
    Allen, J
    Hauger, M
    Loughlin, H
    Moore, T
    Villalona, M
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S203 - S203
  • [40] CAPECITABINE AND GEMCITABINE (GEMCAP) IN HEAVILY PRE-TREATETED PATIENTS (PTS) WITH METASTATIC BREAST CANCER (MBC). PRELIMINARY DATA
    Angelini, F.
    Maritati, R.
    Evangelista, M. L.
    Bianchetti, S.
    Brunetti, M.
    Bussa, S.
    [J]. ANNALS OF ONCOLOGY, 2009, 20
12345